Website History:

1/7/19:     Initial website launch

2/4/19:     CSTD section added

2/24/19:   Deactivation section added

3/22/19:   Case study added to deactivation section

3/31/19:   Hyaluronidase paragraph added to monoclonal antibody section

3/31/19:   Additional information on gowns added to PPE section

4/5/19:     Added section on CSTD testing

4/17/19:   Added custom spill kit contents

4/21/19:   Updated wipe testing company table

4/26/19:   Added excreta information on erdafitinib

7/5/19:     Added selinexor to excretion table

8/20/19:   Added pexidartinib  to excretion table

8/22/19:   Updated deactivation page; added entrectinib to excretion table

8/31/19:   Updated information on regorafenib, added darolutamide and fedratinib

9/16/19:   Revised carbon monoxide link to direct to CDC website

9/20/19:   Added information on Oxivir and revisions to decontamination page

11/8/2019: Added information on polatuzumab vedotin to excretion table

Disclaimer: Information presented on these pages is based on cited references and expert opinion. Information can change at any time. Healthcare professionals should assess whether newer data is available as this site is not responsible for errors or out of date information.